CNW Group
Global Health Clinics Ltd. (CSE: MJRX) (FRANKFURT: L002) ("Global Health" or the "Company") is pleased to announce a memorandum of understanding with Cultivarium. The partnership will allow Global Health Clinics' Wonder Scientific division to research and develop psilocybin products to become a supplier of clean-start psilocybe genetics for psychedelics research and novel drug development sectors. This Company is focused on developing new products to supply clinical trials, regulated markets and